{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:54Z","timestamp":1790892654084,"version":"4.1.0"},"reference-count":17,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1507\/endocrj.ej13-0165","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T23:11:45Z","timestamp":1372374705000},"page":"1085-1094","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"],"prefix":"10.1507","volume":"60","author":[{"given":"Hiroshi","family":"Arima","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Field of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Oiso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Field of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Vinter","family":"Juul","sequence":"additional","affiliation":[{"name":"Ferring International Pharmascience Center, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Peter","family":"N\u00f8rgaard","sequence":"additional","affiliation":[{"name":"Ferring International Pharmascience Center, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Robertson GL (2001) Disorders of water balance. In Brook CGD and Hindmarsh PC (eds) Clinical Pediatric Endocrinology (4th<\/sup>). Blackwell Science, Oxford: 193–221."},{"key":"2","unstructured":"2. Rittig S, Siggaard C, Ozata M, Yetkin I, Gregersen N, et al. (2002) Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor. J Clin Endocrinol Metab<\/i> 87: 3351–3355."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, et al. (2000) Central diabetes insipidus in children and young adults. N Engl J Med<\/i> 343: 998–1007.","DOI":"10.1056\/NEJM200010053431403"},{"key":"4","unstructured":"4. Robson WL, Leung AK, Nørgaard JP (2007) The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol<\/i> 178: 24–30."},{"key":"5","unstructured":"5. Kim RJ, Malattia C, Allen M, Moshang T Jr, Maghnie M (2004) Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev<\/i> 2: S1 115–123."},{"key":"6","unstructured":"6. Weiss JP, Zinner NR, Klein BM, Nørgaard JP (2012) Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn<\/i> 31: 441–447."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fukuda I, Hizuka N, Takano K (2003) Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. Endocr J<\/i> 50: 437–443.","DOI":"10.1507\/endocrj.50.437"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lam KS, Wat MS, Choi KL, Ip TP, Pang RW, et al. (1996) Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharmacol<\/i> 42: 379–385.","DOI":"10.1046\/j.1365-2125.1996.39914.x"},{"key":"9","unstructured":"9. Williams TD, Dunger DB, Lyon CC, Lewis RJ, Taylor F, Lightman SL (1986) Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab<\/i> 63: 129–132."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Westgren U, Wittstrom C, Harris AS (1986) Oral desmopressin in central diabetes insipidus. Arch Dis Child<\/i> 61: 247–250.","DOI":"10.1136\/adc.61.3.247"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fjellestad A and Czernichow P (1986) Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP). Acta Paediatr Scand<\/i> 75: 605–610.","DOI":"10.1111\/j.1651-2227.1986.tb10259.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Catrina SB, Rotarus R, Wivall IL, Coculescu M, Brismar K (2004) The influence of vasopressin deficiency and acute desmopressin administration on melatonin secretion in patients with central diabetes insipidus. J Endocrinol Invest<\/i> 27: 47–51.","DOI":"10.1007\/BF03350910"},{"key":"13","unstructured":"13. Vande Walle J, Stockner M, Raes A, Nørgaard JP (2007) Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf<\/i> 2: 232–238."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gutmark-Little I, Repaske DR, Backeljauw PF (2010) Efficacy and safety of intranasal desmopressin acetate administered orally for the management of infants with neurogenic diabetes insipidus (DI). 92nd Annual Endocrine Society Meeting, P3–324 (Abstract).","DOI":"10.1210\/endo-meetings.2010.PART3.P7.P3-324"},{"key":"15","unstructured":"15. Juul KV, Bichet DG, Nørgaard JP (2011) Desmopressin duration of antidiuretic action in patients with central diabetes insipidus. Endocrine<\/i> 40: 67–74."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fjellestad-Paulsen A, Tubiana-Rufi N, Harris A, Czernichow P (1987) Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Acta Endocrinol (Copenh)<\/i> 115: 307–312.","DOI":"10.1530\/acta.0.1150307"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fjellestad-Paulsen A, Paulsen O, d\u2019Agay-Abensour L, Lundin S, Czernichow P (1993) Central diabetes insipidus: oral treatment with dDAVP. Regul Pept<\/i> 45: 303–307.","DOI":"10.1016\/0167-0115(93)90225-W"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/9\/60_EJ13-0165\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:39:13Z","timestamp":1618295953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/9\/60_EJ13-0165\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0165","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}